Advances in cardioprotective strategies: Bridging traditional pharmacotherapy and regenerative medicine
Cardiovascular diseases (CVDs) remain the leading global cause of death and disability, underscoring the need for improved therapies. Key emerging strategies include pharmacological cardioprotection, cell-based therapies and the use of exosomes as therapeutic agents and biomarkers. Aim of this study...
Saved in:
Main Authors: | Hladkykh Fedir V., Matvieienko Mariia M., Liadova Tetiana I, Karafulidi Olha V., Komorovsky Roman R. |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2025-01-01
|
Series: | Scripta Medica |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2025/2490-33292503521H.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE
by: O. V. Gaisenok, et al.
Published: (2015-09-01) -
Heart rate-lowering antianginal medications: what determines their choice?
by: Yu. M. Lopatin
Published: (1970-01-01) -
The role of platelet derived exosomes in regenerative medicine
by: Seyyede Fatemeh Shams, et al.
Published: (2025-01-01) -
Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01) -
Physiology and pathology of extracellular vesicules
by: M. A. Panteleev, et al.
Published: (2017-04-01)